| Wed 2 May 2012, 7:43 | | DMC - DiamondCorp plc - Appointment of a Non-executive Director |
|
DMC
DMC
DMC - DiamondCorp plc - Appointment of a Non-executive Director
DiamondCorp plc
JSE share code: DMC
AIM share code: DCP
ISIN: GB00B183ZC46
(Incorporated in England and Wales)
(Registration number 05400982)
(SA company registration number 2007/031444/10)
(`DiamondCorp` or `the Company`)
Directorate Change
The Board of Directors of DiamondCorp plc ("DiamondCorp" or "the Company")
is pleased to announce the appointment of Michael Toxvaerd to the Board as
Non-executive Director with immediate effect.
Mr Toxvaerd is Chief Investment Officer of HBG Management Partners, a
leading UK private equity firm serving high net worth private and
institutional clients in the Arabian Gulf. He has more than 15 years of
experience founding, operating, acquiring, integrating and leading a
variety of businesses in private equity and public markets at board and
senior management level. Mr Toxvaerd was most recently Founder, CEO and
Deputy Chairman of NeutraHealth plc, an AIM listed company. He holds an MBA
from Cranfield School of Management.
Mr Toxvaerd is also a non-executive Director of European Islamic Investment
Bank plc ("EIIB"), an AIM listed company and significant shareholder of
DiamondCorp. EIIB is interested in a total of 55,761,412 ordinary shares in
the Company, which represents approximately 23.02% of the issued share
capital of the Company.
HBG Management Partners, via its wholly owned subsidiaries, is interested
in 274,633,802 ordinary shares of EIIB, which represents approximately
15.55% of the issued share capital of EIIB.
Euan Worthington, Chairman commented:
"We are very pleased to welcome Michael on to the Board and believe that
his financial background will help to finalise the financing for Lace while
his entrepreneurial experience will help us evaluate other opportunities in
the diamond sector".
Please see the Appendix below for further disclosure with regard to Michael
Toxvaerd in accordance with the AIM Rules for Companies.
Contact details:
DiamondCorp plc
Paul Loudon, Chief Executive Officer
+44 20 3151 0970 / +27 56 212 2308
Fairfax I.S. PLC
AIM Nomad and Joint Broker
Ewan Leggat/Laura Littley
+44 207 598 5368
Ocean Equities Limited
Joint Broker
Guy Wilkes
+44 207 786 4370
PSG Capital (Pty) Limited
JSE Sponsor
John-Paul Dicks
+27 21 887 9602
Russell & Associates
Charmane Russell/Marion Brower
+27 11 880 3924
1 May 2012
APPENDIX
Further disclosures regarding Michael Toxvaerd as required by the AIM Rules
for Companies.
Full name: Michael Hjelm Toxvaerd
Age: 37
Michael Toxvaerd currently holds, or has during the five years preceding
the date of this announcement held, the following directorships or
partnerships:
Current Past
European Islamic Investment Aquacell International Limited
Bank Plc
HBG Holdings UK LLP Bg2zero Ltd
HBG Small Cap 2 LTD Biocare 2000 Limited
HBG Small Cap 3 LTD Biocare Agricultural Supplies Limited
HBG Small Cap 4 LTD Biocare Clinics Limited
HBG Small Cap SPV 1 Limited Biocare (Holdings) Limited
Letssavesomemoney Limited Biocare International Limited
PAF Ventures Limited Biocare Limited
PAF Entertainment Limited Brunel Healthcare Limited
Brunel Healthcare Manufacturing
Limited
Natural Wellbeing Limited
Neutrahealth plc
Nutrahealth Limited
Nutrahealth UK Limited
Perrigo Pharma Limited
Totally Nourish Limited
Date: 02/05/2012 07:43:01 Produced by the JSE SENS Department.
The SENS service is an information dissemination service administered by the
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or
implicitly, represent, warrant or in any way guarantee the truth, accuracy or
completeness of the information published on SENS. The JSE, their officers,
employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature,
howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
